DE2921829C2 - - Google Patents

Info

Publication number
DE2921829C2
DE2921829C2 DE2921829A DE2921829A DE2921829C2 DE 2921829 C2 DE2921829 C2 DE 2921829C2 DE 2921829 A DE2921829 A DE 2921829A DE 2921829 A DE2921829 A DE 2921829A DE 2921829 C2 DE2921829 C2 DE 2921829C2
Authority
DE
Germany
Prior art keywords
cells
tumor
suspension
preparation
streptococcus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2921829A
Other languages
German (de)
English (en)
Other versions
DE2921829A1 (de
Inventor
Yasuhisa Yokohama Kanagawa Jp Takeda
Takashi Omiya Saitama Jp Matsuno
Mihoko Tokio/Tokyo Jp Ohtaka
Hiroki Iruma Saitama Jp Mitsui
Tsutomu Saitama Jp Kawaguchi
Hisako Tokio/Tokyo Jp Masuda
Hiroshi Sayama Saitama Jp Okazaki
Mitsuaki Kamifukuoka Saitama Jp Handa
Yutaka Omiya Saitama Jp Sugawara
Haruki Chofu Tokio/Tokyo Jp Ogawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of DE2921829A1 publication Critical patent/DE2921829A1/de
Application granted granted Critical
Publication of DE2921829C2 publication Critical patent/DE2921829C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/46—Streptococcus ; Enterococcus; Lactococcus

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19792921829 1978-05-29 1979-05-29 Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung Granted DE2921829A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6341878A JPS54157815A (en) 1978-05-29 1978-05-29 Anti-tumor substance and its preparation

Publications (2)

Publication Number Publication Date
DE2921829A1 DE2921829A1 (de) 1979-12-06
DE2921829C2 true DE2921829C2 (cg-RX-API-DMAC10.html) 1987-08-13

Family

ID=13228713

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792921829 Granted DE2921829A1 (de) 1978-05-29 1979-05-29 Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung

Country Status (7)

Country Link
US (1) US4349541A (cg-RX-API-DMAC10.html)
JP (1) JPS54157815A (cg-RX-API-DMAC10.html)
CA (1) CA1135184A (cg-RX-API-DMAC10.html)
CH (1) CH649709A5 (cg-RX-API-DMAC10.html)
DE (1) DE2921829A1 (cg-RX-API-DMAC10.html)
FR (1) FR2427099A1 (cg-RX-API-DMAC10.html)
GB (1) GB2024857B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5933223A (ja) * 1982-08-20 1984-02-23 Koken Kk 人の悪性腫瘍細胞増殖抑制剤
JPH03116624U (cg-RX-API-DMAC10.html) * 1990-03-14 1991-12-03
JPH0416837U (cg-RX-API-DMAC10.html) * 1990-05-30 1992-02-12

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1132676A (en) * 1966-03-08 1968-11-06 Chugai Pharmaceutical Co Ltd Anti-tumour preparation and process for preparing the same
GB1153113A (en) * 1967-01-20 1969-05-21 Chugai Pharmaceutical Co Ltd Method of Treating Hemolytic Streptococci and the Resultant Preparation containing the same
US3632746A (en) * 1967-08-30 1972-01-04 Chugai Pharmaceutical Co Ltd Dried stable anti-tumor preparations and process for preparing the same
US4002736A (en) * 1974-12-16 1977-01-11 Pankratz Duane C Porcine bacterin

Also Published As

Publication number Publication date
US4349541A (en) 1982-09-14
JPS6234726B2 (cg-RX-API-DMAC10.html) 1987-07-28
CA1135184A (en) 1982-11-09
GB2024857A (en) 1980-01-16
GB2024857B (en) 1982-08-04
DE2921829A1 (de) 1979-12-06
JPS54157815A (en) 1979-12-13
FR2427099B1 (cg-RX-API-DMAC10.html) 1983-11-18
FR2427099A1 (fr) 1979-12-28
CH649709A5 (de) 1985-06-14

Similar Documents

Publication Publication Date Title
DE3007412A1 (de) Antitumormittel
DE2926406A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
DE69026371T2 (de) Heilmittel und verfahren zur inhibierung der vaskularisierung von tumoren
DE2153232C3 (de) Verfahren zur Herstellung einer Amylose
DE1617397C3 (de) Herstellung eines tumorstatisch wirkenden Mittels durch Züchten von Streptococcus haemolyticus
DE2921829C2 (cg-RX-API-DMAC10.html)
DE2043971C3 (de) Antitumorsubstanz aus haemolytischen Streptococcen
CH639133A5 (de) Verfahren zur herstellung einer antitumor wirksamen substanz mit immunostimulierender wirkung.
CH423095A (de) Verfahren zur Herstellung eines Tollwutimpfstoffes
DE4104728A1 (de) Medikament zur behandlung der dermatitis
DE2148452C3 (de) Verwendung einer wasserunlöslichen Protoplastmembranfraktion aus haemolytischen Streptococcen mit tumorstatischer Wirkung bei der Bekämpfung maligner Geschwulste
DE1717100A1 (de) Verfahren zur Herstellung von anticarcinomatoesen Praeparaten haemolytischer Streptococcen
DE2152112B2 (de) Impfstoff gegen Pseudomonas aeruginosa
DE1792390A1 (de) Getrocknetes stabiles Praeparat mit Antitumorwirkung,das Zellen von haemolytischen Streptococcen enthaelt sowie Verfahren zu seiner Herstellung
DE1115888B (de) Verfahren zur Herstellung eines Streptokinase-Praeparates
DE1929355C3 (de) Thiopeptin-Antibiotika und deren Verwendung in Futtermittelzusätzen
DE2165401C3 (de) Inaktivierter Kombinationsimpfstoff zum Immunisieren von Geflügel gegen Infektion der Atmungsorgane
DE3030107C2 (cg-RX-API-DMAC10.html)
AT96830B (de) Verfahren zur Herstellung eines Nährbodens für Influenzabazillen und zur Herstellung von Impfstoffen aus diesen.
DE1717100C (de) Verfahren zur Herstellung von Prapara ten hamolytischer Streptococcen zur unter stutzenden Behandlung von Carcinomerkrankun gen
DE2011935B2 (de) Enzym mit der Fähigkeit zur Lyse der Zellen von Zahnkaries erzeugenden Mikroorganismen, Verfahren zur Herstellung dieses Enzyms sowie ein Präparat zur Verhütung und Behandlung von Zahnkaries
DE1227614B (de) Verfahren zur Herstellung von BCG-Vaccinen
DE1954218C3 (de) Verfahren zur Herstellung von Protease durch aerobes Züchten eines Bacillus-Stammes
AT110561B (de) Verfahren zur Herstellung von Scharlachserum.
AT205663B (de) Verfahren zur Herstellung eines therapeutisch wirksamen Darmbaktierienpräparates

Legal Events

Date Code Title Description
OAR Request for search filed
OC Search report available
8128 New person/name/address of the agent

Representative=s name: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. VOSSIUS, D.,

8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: C12N 1/20

D2 Grant after examination
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Free format text: VOSSIUS, V., DIPL.-CHEM. DR.RER.NAT. TAUCHNER, P., DIPL.-CHEM. DR.RER.NAT. HEUNEMANN, D., DIPL.-PHYS. DR.RER.NAT., PAT.-ANWAELTE, 8000 MUENCHEN

8339 Ceased/non-payment of the annual fee